InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Kovacs Shane William Charles. Director active across 1 company, notably Olema Pharmaceuticals, Inc.. Aggregated, 7 filings have been published. Split: 2 buys · 0 sell. Activity tracked since 20 November 2023. The latest transaction was filed on 9 December 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
7 of 7 declarations